EUVIMEDEUVIMED entdecken
MetaanalyseSystematische ÜbersichtOpen Access · CC BY 4.0

Long-term efficacy and safety of left atrial appendage closure vs. oral anticoagulation in atrial fibrillation: a meta-analysis of randomized controlled trials

Paschalis Karakasis iD, Stylianos Tzeis iD, Athanasios Samaras iD, Konstantinos Vlachos iD, Konstantinos Pamporis iD, Panagiotis Theofilis iD, Apostolos Tzikas iD, Antonios P Antoniadis iD, Pierre Jaïs iD, Nikolaos Fragakis iD

Europace · 03.07.2026 · 28 (7)

DOI: 10.1093/europace/euag159 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Europace, online erschienen am 23.07.2026. Verfasst von Paschalis Karakasis und 9 weiteren Autor:innen. Beteiligte Einrichtung: Second Department of Cardiology, Hippokration General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece. Hauptthemen laut MEDLINE: Atrial Fibrillation, Left Atrial Appendage Closure, Anticoagulants, Stroke. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Left atrial appendage closure (LAAC) has emerged as an alternative to oral anticoagulation (OAC) for stroke prevention in atrial fibrillation (AF), but its long-term comparative efficacy remains uncertain. This systematic review and meta-analysis evaluated randomized controlled trials (RCTs) comparing LAAC with OAC in AF. Methods and results MEDLINE, Embase, Scopus, and the Cochrane Database of Systematic Reviews were searched through 8 April 2026. Risk ratios (RR) with 95% confidence intervals (CI) were pooled using random-effects models. Certainty of evidence (CoE) was assessed using GRADE. Six RCTs involving 7004 participants were included (3681 assigned to LAAC and 3323 to OAC). Compared with OAC, LAAC resulted in a significantly higher risk of ischaemic stroke or systemic embolism (134 vs. 80 events; RR 1.41, 95% CI 1.07–1.86; moderate CoE). No significant differences were observed for any stroke or systemic embolism (RR 1.10, 95% CI 0.87–1.39; moderate CoE), all-cause mortality (RR 0.92, 95% CI 0.77–1.10; high CoE), cardiovascular mortality (RR 0.90, 95% CI 0.67–1.21; moderate CoE), non-cardiovascular mortality (RR 0.92, 95% CI 0.75–1.12; moderate CoE), major bleeding (RR 0.91, 95% CI 0.77–1.08; high CoE), or haemorrhagic stroke (RR 0.58, 95% CI 0.28–1.17; moderate CoE). LAAC reduced the risk of nonprocedural clinically relevant bleeding compared with OAC (RR 0.50, 95% CI 0.43–0.59; high CoE).

Conclusion

In patients with AF, LAAC results in a higher risk of ischaemic stroke or systemic embolism than an OAC-based strategy. Compared with OAC, LAAC has no effect on major bleeding or mortality and does not reduce haemorrhagic stroke.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationLeft Atrial Appendage ClosureAnticoagulantsStrokeAtrial AppendageHumansRandomized Controlled Trials as TopicAdministration, OralTreatment OutcomeEmbolism

Stichwörter der Autor:innen

Atrial fibrillationBleedingIschemic strokeLeft atrial appendage closureOral anticoagulationStroke preventionThromboembolism

Substanzen

Anticoagulants

Autor:innen und Institutionen

  • Second Department of Cardiology, Hippokration General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Department of Cardiology, Mitera Hospital, 6, Erythrou Stavrou Str. 151 23, Marousi, Athens, Greece.
  • Electrophysiology and Heart Modeling Institute, IHU Liryc, Fondation Bordeaux Université and Université de Bordeaux, INSERM U1045, Pessac, France.
  • Cardiac Arrhythmia Department, INSERM U1045, CHU de Bordeaux, Pessac, France.
  • Electrophysiology Department, Hygeia Hospital, Athens, Greece.
  • First Department of Cardiology, School of Medicine, National and Kapodistrian University of Athens, Hippokration General Hospital, Athens, Greece.

ORCID-Profile: Paschalis Karakasis, Stylianos Tzeis, Athanasios Samaras, Konstantinos Vlachos, Konstantinos Pamporis, Panagiotis Theofilis, Apostolos Tzikas, Antonios P Antoniadis, Pierre Jaïs, Nikolaos Fragakis

Zitieren

APA

Karakasis, P., Tzeis, S., Samaras, A., Vlachos, K., Pamporis, K., Theofilis, P., Tzikas, A., Antoniadis, A. P., Jaïs, P., & Fragakis, N. (2026). Long-term efficacy and safety of left atrial appendage closure vs. oral anticoagulation in atrial fibrillation: a meta-analysis of randomized controlled trials. Europace, 28(7). https://doi.org/10.1093/europace/euag159

Vancouver

Karakasis P, Tzeis S, Samaras A, Vlachos K, Pamporis K, Theofilis P, et al. Long-term efficacy and safety of left atrial appendage closure vs. oral anticoagulation in atrial fibrillation: a meta-analysis of randomized controlled trials. Europace. 2026;28(7). doi:10.1093/europace/euag159

BibTeX
@article{Karakasis2026,
  author = {Karakasis, Paschalis and Tzeis, Stylianos and Samaras, Athanasios and Vlachos, Konstantinos and Pamporis, Konstantinos and Theofilis, Panagiotis and Tzikas, Apostolos and Antoniadis, Antonios P and Jaïs, Pierre and Fragakis, Nikolaos},
  title = {Long-term efficacy and safety of left atrial appendage closure vs. oral anticoagulation in atrial fibrillation: a meta-analysis of randomized controlled trials},
  journal = {Europace},
  year = {2026},
  volume = {28},
  number = {7},
  doi = {10.1093/europace/euag159}
}
Kostenlos starten →